White Paper

Data On The Go: Mobile Application Considerations For Clinical Trials And Beyond

Source: Advarra
Managing Mobility

With global smartphone subscriptions expected to exceed 7.3 billion by 2025, the utilization of apps for participant engagement and data collection in research has gained substantial traction. The COVID-19 pandemic has further hastened the adoption and demand for research apps that enable remote data collection. Given this context, what factors should be taken into account when selecting or implementing an app for research involving human subjects?

When considering the integration of an app into research, it becomes imperative to comprehensively understand its role within the research process, the legal dimensions associated with its utilization, and the implications for participants, sponsors, and institutional review boards (IRBs) in relation to incorporating mobile applications into research endeavors.

This white paper delves into fundamental definitions, navigates through the regulatory landscape, and examines common applications of apps in research. Moreover, it offers insights into the evaluation of apps by research teams and IRBs, and delves into participant considerations, particularly the safeguarding of user privacy and confidentiality.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader